NCT01393626

Who might be able to join this trial:

• You are between 18 and 75 years old (note: the upper age limit is 64 in India and 65 in the Netherlands)
• You have been diagnosed with Crohn's disease for at least 6 months before the screening visit
• Your Crohn's disease is currently moderately to severely active, affecting the small intestine, large intestine, or both, as measured by a standard scoring system called the CDAI (confirm with trial site)

Who may not be able to join:

• You have been diagnosed with a different type of bowel disease, such as ulcerative colitis or indeterminate colitis, or have symptoms that suggest you may have ulcerative colitis
• You have Crohn's disease but have never received any treatment for it before
• You have taken certain immune-suppressing medications called azathioprine, 6-mercaptopurine, or methotrexate within the past 2 weeks
• You have received a type of treatment called anti-TNFα therapy (a specific kind of medication that targets inflammation) within the past 8 weeks
• You have received interferon therapy within the past 8 weeks
• You have taken certain other immune-suppressing medicines (cyclosporine, mycophenolate, or tacrolimus) within the past 4 weeks
• You have received corticosteroids given directly into a vein (by IV) within the past 2 weeks

Important: Always verify eligibility with the trial site directly before applying.